Syros Pharmaceuticals, Inc. (30)

Browse by Contract Category

Contracts

Master Collaboration Agreement dated March 7, 2022 between Syros Pharmaceuticals, Inc. and QIAGEN Manchester Limited (Filed With SEC on May 16, 2022)
Form of Restricted Stock Unit Agreement under 2022 Inducement Stock Incentive Plan (Filed With SEC on March 15, 2022)
Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 15, 2022)
Form of Nonstatutory Stock Option Agreement for Inducement Awards (Filed With SEC on October 13, 2021)
Amendment No. 1 to Amended and Restated Cancer License Agreement, dated January 8, 2021, by and between the Registrant and TMRC Co., Ltd (Filed With SEC on May 6, 2021)
Lease Termination Agreement dated as of November 1, 2019 between Syros Pharmaceuticals, Inc. and 620 Memorial Leasehold LLC (Filed With SEC on November 4, 2019)
Form of Nonstatutory Stock Option Agreement under 2022 Inducement Stock Incentive Pla (Filed With SEC on March 15, 2022)
2022 Inducement Stock Incentive Plan (Filed With SEC on March 15, 2022)
Offer Letter, effective September 27, 2021, between Syros Pharmaceuticals, Inc. and Conley Chee (Filed With SEC on November 5, 2021)
Offer Letter, effective October 12, 2021, between Syros Pharmaceuticals, Inc. and Jason Haas (Filed With SEC on October 13, 2021)
Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 4, 2021)
Underwriting Agreement, dated January 19, 2021, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several... (Filed With SEC on January 20, 2021)
Form of Pre-Funded Warrant (Filed With SEC on December 7, 2020)
Registration Rights Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on December 7, 2020)
Securities Purchase Agreement, dated December 4, 2020, by and among Syros Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on December 7, 2020)
Form of Warrant to Purchase Common Stock or Pre-Funded Warrants (Filed With SEC on December 7, 2020)
Asset Purchase Agreement, dated as of December 4, 2020, by and between Syros Pharmaceuticals, Inc. and Orsenix, LLC (Filed With SEC on December 7, 2020)
License and Collaboration Agreement dated December 17, 2019 by and between the Registrant and Global Blood Therapeutics, Inc (Filed With SEC on March 5, 2020)
Letter Agreement dated November 18, 2019 by and between the Registrant and Incyte Corporation (Filed With SEC on March 5, 2020)
Offer Letter dated April 24, 2013 by and between the Registrant and Eric R. Olson, Ph.D (Filed With SEC on March 5, 2020)
Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 5, 2020)
Loan and Security Agreement, dated February 12, 2020, by and among Syros Pharmaceuticals, Inc. and Oxford Finance LLC, as collateral agent and lender (Filed With SEC on February 13, 2020)
Consulting Agreement dated August 8, 2012 between the Registrant and Richard A. Young, Ph.D., as amended (Filed With SEC on November 12, 2019)
Form of Series A Convertible Preferred Stock Certificate (Filed With SEC on April 8, 2019)
Form of Class A Warrant (Filed With SEC on April 8, 2019)
Underwriting Agreement relating to the Preferred Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as... (Filed With SEC on April 8, 2019)
Underwriting Agreement relating to the Common Offering, dated April 5, 2019, by and among Syros Pharmaceuticals, Inc., Cowen and Company, LLC and Piper Jaffray & Co., as... (Filed With SEC on April 8, 2019)
Amended and Restated Cancer License Agreement dated April 28, 2016 by and between the Registrant and TMRC Co., Ltd (Filed With SEC on March 7, 2019)
Form of Restricted Stock Unit Agreement under 2016 Stock Incentive Plan (Filed With SEC on March 7, 2019)
Lease dated January 8, 2019 between the Company and DIV 35 CPD, LLC (Filed With SEC on January 11, 2019)